AstraZeneca is said to be in talks to acquire US drugmaker Bristol Myers Squibb in a deal that would create a pharmaceutical group worth almost $400bn (£300bn).
The proposed transaction, first reported by the Financial Times this morning, would rank among the largest pharmaceutical mergers ever completed and create the world's fourth-largest listed drugmaker by market value
Highlighted Content
For most employees, pension saving happens in the background. Contributions are paid in each month, but few people make an active investment choice.
© 2019 Perspective Publishing Privacy & Cookies